49 results on '"S. Guleria"'
Search Results
2. A Multicenter Cohort Study From India of 75 Kidney Transplants in Recipients Recovered After COVID-19
- Author
-
Deepak Shankar Ray, Dinesh Khullar, Umesh T Varyani, Vishwanath Siddini, Dinesh Kumar Yadav, Rushi Deshpande, Anil M. S. Kumar, M.M. Bahadur, Vijay Kher, Pranaw Kumar Jha, Urmila Anandh, S. Guleria, Abi Abraham M, Kamal Kaswan, Manoj R. Gumber, Suraj Godara, Ashay Shingare, Shailesh Kakde, Hari Shankar Meshram, Anil Kumar Bhalla, Vivek B Kute, Himanshu V Patel, Sanjeev Gulati, Sonal Dalal, Umapati Hegde, Manish Jain, Ashish Sharma, Sharmila Thukral, Vivek M. Pathak, Rabi Ranjan Sow Mondal, Deepesh Benjamin Kenwar, and Raj Kumar Sharma
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,India ,030230 surgery ,Asymptomatic ,Donor Selection ,03 medical and health sciences ,0302 clinical medicine ,Interquartile range ,Internal medicine ,Humans ,Medicine ,Survivors ,Prospective cohort study ,Kidney transplantation ,Aged ,Retrospective Studies ,Transplantation ,business.industry ,Patient Selection ,COVID-19 ,Retrospective cohort study ,Immunosuppression ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Treatment Outcome ,Kidney Failure, Chronic ,Female ,030211 gastroenterology & hepatology ,medicine.symptom ,business ,Follow-Up Studies ,Cohort study - Abstract
Background There is limited current knowledge on feasibility and safety of kidney transplantation in COVID-19 survivors. Methods We present a retrospective cohort study of 75 kidney transplants in patients who recovered from polymerase chain reaction (PCR) confirmed COVID-19 performed across 22 transplant centers in India from July 3, 2020 to January 31, 2021. We detail demographics, clinical manifestations, immunosuppression regimen, laboratory findings, treatment and outcomes. Patients with a previous diagnosis of COVID-19 were accepted after documenting 2 negative SARS-CoV-2 PCR tests, normal chest imaging with complete resolution of symptom for at least 28 days and significant social distancing for 14 days prior to surgery. Results Clinical severity in patients ranged from asymptomatic (n=17, 22.7%), mild(n=36,48%), moderate(n=15,20%) and severe(n=7,9.3%) disease. Median duration between PCR positive to transplant was 60 days (overall) and, increased significantly from asymptomatic, mild, moderate and severe disease (49,57,83,94 days, P-value 0.019) respectively. All recipients and donors were asymptomatic with normal creatinine after surgery at a median (interquartile range) follow up of 81 (56-117) days without any complications relating to surgery or COVID-19. Patient and graft survival was 100%, and acute rejection was reported in 6.6%. Conclusions Prospective kidney transplant recipients post-COVID-19 can be considered for transplantation after comprehensive donor and recipient screening before surgery using a combination of clinical, radiologic, and laboratory criteria, careful pre-transplant evaluation, and individualized risk-benefit analysis. Further large-scale prospective studies with longer follow-up will better clarify our initial findings. Till date, this remains the first largest study of kidney transplantation in COVID-19 survivors.Supplemental Visual Abstract; http://links.lww.com/TP/C180.
- Published
- 2021
- Full Text
- View/download PDF
3. Perception of patients getting teleconsultation in an e-OPD during Covid pandemic
- Author
-
Nitin Patiyal, Dinesh Kansal, Kunwar S D S Guleria, Arun Kumar Negi, and Vikrant Kanwar
- Subjects
010302 applied physics ,Remote Consultation ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Computer science ,Pharmacy ,02 engineering and technology ,Virus diseases ,Rating score ,medicine.disease ,01 natural sciences ,020202 computer hardware & architecture ,Patient satisfaction ,Electronic prescribing ,0103 physical sciences ,Pandemic ,0202 electrical engineering, electronic engineering, information engineering ,medicine ,Medical emergency ,business - Abstract
Background: Corona Virus Disease (COVID-19) was declared as Global Pandemic by W.H.O. on 11th March 2020. As nationwide lockdown was imposed from 21st March 2020 in India, teleconsultation project known as eSanjeevani: Stay Home OPD” was launched by Honourable Union Health Minister. This facility was also started by the Department of Health & Family Welfare, Govt. of Himachal Pradesh at our center; Dr. Rajendra Prasad Govt. Medical College (Dr. RPGMC), Kangra at Tanda from 20th April 2020 onwards. Aim & Objective: To analyse the parameters influencing teleconsultation service from the perspective of patients during Covid-19 pandemic. Materials and Methods: This cross-sectional descriptive study was conducted through a semi-structured 10-point feedback questionnaire. The feedback was collected telephonically. A total of 131 responses were noted and analysed accordingly. Results: Out of 131 patients, 71 (54%) were males and 60 (46%) were females. All of them 131 (100%) accepted the legibility of e-prescription, and the majority (91%) of them were comfortable in procuring (downloading) the same. (83%) respondents preferred teleconsultation services over conventional OPD based services and (98%) patients also recommended teleconsultation platform to others. Conclusion: Mean rating score was 8.9±1.04 out of 10 which clearly shows that majority of patients were satisfied with teleconsultation services availed by them through Dr. RPGMC Tanda hub. Keywords: COVID- 19, Pandemics, Remote Consultation, Patient Satisfaction, Electronic Prescribing, eSanjeevni OPD.
- Published
- 2021
- Full Text
- View/download PDF
4. Utilization of outpatient eSanjeevani National Teleconsultation Service during COVID- 19 pandemic in a public healthcare institution in North India
- Author
-
Arun Kumar Negi, Vikrant Kanwar, Kansal Dinesh, Nitin Patiyal, and Kunwar S D S Guleria
- Subjects
Remote Consultation ,Telemedicine ,020205 medical informatics ,Computer science ,business.industry ,Cross-sectional study ,Workload ,Pharmacy ,02 engineering and technology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Pandemic ,0202 electrical engineering, electronic engineering, information engineering ,medicine ,030212 general & internal medicine ,Medical emergency ,Medical prescription ,Rural area ,business - Abstract
Objectives: To analyse the utilization of outpatient eSanjeevani Telemedicine Service during COVID pandemic in a public healthcare institution in North India by profiling the attributes of patients availing online video consultation in terms of gender, age, urban-rural, organ-system involvement, speciality of OPD service given and prescription analysis. Materials and Methods: This is a descriptive, cross sectional study done at Dr. Rajendra Prasad Govt. Medical College which served as a hub in a hub & spoke type model for rendering online OPD consultations; on a software platform “eSanjeevani” developed by Centre for Development of Advanced Computing (C-DAC) Mohali. Data from 206 audio+video based online tele-OPD consultations & their prescriptions were analysed. Results: Out of a total 206, 114 (55%) were males and 92 (45%) were females. Mean ± S.D. age of patients was 42 ±19.6 years. 146 (71%) connected from rural area and 60 (29%) from urban area. 38 (18%) patients required to be referred to the health-care centre and 46 (22%) patients required a review after blood biochemistry investigations. 76 (37%) were from district Kangra of Himachal Pradesh. The most common organ system involved was musculoskeletal system (19%) followed by skin (18.4%) and gastrointestinal system (16%). The most commonly prescribed class of drugs were NSAIDs & analgesics (36%) antimicrobials (23%) and antihistaminics (18%). Conclusion: Telemedicine is an innovative solution to many of the challenges posed by COVID-19 pandemic. It can help substantially in decreasing the OPD workload in hospitals & decreasing infection chances for both patients & hospital staff. Keywords: COVID- 19, Remote Consultation, Teleconsultation, Telemedicine.
- Published
- 2021
- Full Text
- View/download PDF
5. NOTTO COVID-19 vaccine guidelines for transplant recipients
- Author
-
S. Guleria, Prem P. Varma, Ashish Sharma, Sanjay K. Agarwal, Kewal Krishan, Manisha Sahay, Vivek Kute, Vasanthi Ramesh, Sunil Kumar, Subhash Gupta, Sunil Shroff, Surendran Sudhindran, Jai Prakash, and Narayan Prasad
- Subjects
medicine.medical_specialty ,RD1-811 ,Population ,Disease ,medicine.disease_cause ,Virus ,Organ transplantation ,Herd immunity ,Special Article ,notto ,Pandemic ,Medicine ,guidelines ,Intensive care medicine ,education ,Coronavirus ,Transplantation ,education.field_of_study ,transplant recipients ,business.industry ,Transmission (medicine) ,covid 19 vaccine ,Diseases of the genitourinary system. Urology ,Nephrology ,Inactivated vaccine ,Surgery ,RC870-923 ,business ,COVID-19 vaccine - Abstract
In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmission and enhance herd immunity. Immuno-compromised patients should not receive live vaccines as they can cause vaccine-related disease and hence the guidelines suggest that all transplant recipients should receive age-appropriate 'inactivated vaccine' as recommended for general population. Though trials have not been undertaken on transplant recipients, efficacy and safety of COVID-19 vaccine have been scientifically documented for few vaccines among the general population.
- Published
- 2021
6. Cortisol as a biomarker of alcohol use in combat veterans: A literature review and framework for future research
- Author
-
Christina Hejl, Steven M. Nelson, Yvette Z. Szabo, Laura Zambrano-Vazquez, Rakeshwar S. Guleria, and Tessa Breeding
- Subjects
medicine.medical_specialty ,Combat Disorders ,Alcohol Drinking ,Hydrocortisone ,business.industry ,Alcohol abuse ,Alcohol ,medicine.disease ,humanities ,Article ,Stress Disorders, Post-Traumatic ,Psychiatry and Mental health ,chemistry.chemical_compound ,Alcoholism ,chemistry ,Research Design ,mental disorders ,Medicine ,Biomarker (medicine) ,Humans ,business ,Psychiatry ,Biomarkers ,Veterans - Abstract
Alcohol use and alcohol use disorders (AUDs) are an increasing concern among veterans, particularly those from recent conflicts in Iraq and Afghanistan. The study of biomarkers in alcohol use and AUD has moved to enhancing the understanding of the development and maintenance of AUDs, as well as investigating its association with clinical severity and potential predictors of treatment response. Cortisol, a glucocorticoid known as a stress hormone, has been linked with both stress and trauma, as well as increased alcohol suppression effects. The present review summarizes existing literature and presents suggestions for future research to evaluate whether cortisol may be a possible biomarker of alcohol use disorder risk in combat veterans. Specifically, aspects of combat deployments and high levels of PTSD, coupled with the stress of reintegration may dysregulate cortisol and increase risk to AUD. There may also be bidirectional impacts, such that alcohol is used as a coping mechanism and can dysregulate hypothalamic pituitary adrenal (HPA) axis functioning and cortisol. In the context of this framework, cortisol may serve as a biomarker for the development of AUD, as well as a biomarker of risk or relapse. This review ends with both theoretical and clinical implications, as well as directions for future research.
- Published
- 2020
7. MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans
- Author
-
Sudhiranjan Gupta, Rakeshwar S. Guleria, and Yvette Z. Szabo
- Subjects
business.industry ,Pituitary-Adrenal System ,Hypervigilance ,Bioinformatics ,behavioral disciplines and activities ,Article ,Stress Disorders, Post-Traumatic ,Fight-or-flight response ,MicroRNAs ,Psychiatry and Mental health ,Distress ,Posttraumatic stress ,Molecular network ,mental disorders ,microRNA ,Humans ,Biomarker (medicine) ,Medicine ,FKBP5 ,medicine.symptom ,business ,Biomarkers ,Biological Psychiatry ,Veterans - Abstract
Posttraumatic stress disorder (PTSD) is a common psychiatric disorder for military Veterans, characterized by hyperarousal, intrusive thoughts, flashbacks, hypervigilance, and distress after experiencing traumatic events. Some of the known physiological effects of PTSD include hypothalamic-pituitary-adrenal (HPA)-axis imbalance, a cortical function resulting in neuronal deficit and changes in behavior. Moreover, excessive discharge of inflammatory molecules and a dysregulated immune system are implicated in the pathophysiology of PTSD. Due to complex nature of this disorder, the biological underpinnings of PTSD remain inexplicable. Investigating novel biomarkers to understanding the pathogenesis of PTSD may reflect the underlying molecular network for therapeutic use and treatment. Circulatory microRNAs (miRNAs) and exosomes are evolving biomarkers that have shown a key role in psychiatric and neurological disorders including PTSD. Given the unique nature of combat trauma, as well as evidence that a large portion of Veterans do not benefit from frontline treatments, focus on veterans specifically is warranted. In the present review, we delineate the identification and role of several miRNAs in PTSD among veterans. An association of miRNA with HPA-axis regulation through FKBP5, a key modulator in PTSD is discussed as an emerging molecule in psychiatric diseases. We conclude that miRNAs may be used as circulatory biomarker detection in Veterans with PTSD.
- Published
- 2021
- Full Text
- View/download PDF
8. Summary of Kidney Disease
- Author
-
Amit X. Garg, Kazunari Tanabe, Philip Kam-Tao Li, Linda Wright, Patricia L. Adams, Michael Cheung, Sandra J. Taler, Mohamed A. Bakr, Dorry L. Segev, Krista L. Lentine, Martin Zeier, Bertram L. Kasiske, Lorenzo Gallon, Catherine A. Garvey, S. Guleria, Andrew S. Levey, and Josefina Alberú
- Subjects
Transplantation ,medicine.medical_specialty ,Consensus ,business.industry ,030232 urology & nephrology ,Kidney donation ,Reviews ,Expert consensus ,Disease ,Guideline ,030230 surgery ,medicine.disease ,3. Good health ,Clinical Practice ,03 medical and health sciences ,0302 clinical medicine ,Nephrology ,Practice Guidelines as Topic ,Living Donors ,Humans ,Medicine ,Renal Insufficiency, Chronic ,business ,Intensive care medicine ,Kidney disease - Abstract
Kidney Disease: Improving Global Outcomes (KDIGO) engaged an evidence review team and convened a work group to produce a guideline to evaluate and manage candidates for living kidney donation. The evidence for most guideline recommendations is sparse and many “ungraded” expert consensus recommendations were made to guide the donor candidate evaluation and care before, during, and after donation. The guideline advocates for replacing decisions based on assessments of single risk factors in isolation with a comprehensive approach to risk assessment using the best available evidence. The approach to simultaneous consideration of each candidate’s profile of demographic and health characteristics advances a new framework for assessing donor candidate risk and for defensible shared decision making., One of the most important tasks we have to undertake is to evaluate and then care for living donors. This paper provides a summary of the KDIGO Guidelines and encapsulates what you will find in the guidelines themselves, which are published in full in a separate supplement. Care of our living kidney donors is not an evidence free void for personal opinion and practice to fill–there are data.
- Published
- 2017
- Full Text
- View/download PDF
9. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
- Author
-
Martin Zeier, Andrew S. Levey, Linda Wright, Amit X. Garg, Michael Cheung, Sandra J. Taler, Mohamed A. Bakr, Krista L. Lentine, Philip Kam-Tao Li, Kazunari Tanabe, Patricia L. Adams, Josefina Alberú, Dorry L. Segev, Bertram L. Kasiske, Catherine A. Garvey, Lorenzo Gallon, and S. Guleria
- Subjects
medicine.medical_specialty ,030232 urology & nephrology ,MEDLINE ,030230 surgery ,Perioperative Care ,03 medical and health sciences ,0302 clinical medicine ,Living Donors ,Humans ,Medicine ,Intensive care medicine ,Transplantation ,business.industry ,Guideline ,medicine.disease ,Kidney Transplantation ,Critical appraisal ,Systematic review ,Family medicine ,Donation ,Kidney Diseases ,business ,Risk assessment ,Supplement ,Kidney disease - Abstract
The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors is intended to assist medical professionals who evaluate living kidney donor candidates and provide care before, during and after donation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach and guideline recommendations are based on systematic reviews of relevant studies that included critical appraisal of the quality of the evidence and the strength of recommendations. However, many recommendations, for which there was no evidence or no systematic search for evidence was undertaken by the Evidence Review Team, were issued as ungraded expert opinion recommendations. The guideline work group concluded that a comprehensive approach to risk assessment should replace decisions based on assessments of single risk factors in isolation. Original data analyses were undertaken to produce a “proof-in-concept” risk-prediction model for kidney failure to support a framework for quantitative risk assessment in the donor candidate evaluation and defensible shared decision making. This framework is grounded in the simultaneous consideration of each candidate's profile of demographic and health characteristics. The processes and framework for the donor candidate evaluation are presented, along with recommendations for optimal care before, during, and after donation. Limitations of the evidence are discussed, especially regarding the lack of definitive prospective studies and clinical outcome trials. Suggestions for future research, including the need for continued refinement of long-term risk prediction and novel approaches to estimating donation-attributable risks, are also provided. In citing this document, the following format should be used: Kidney Disease: Improving Global Outcomes (KDIGO) Living Kidney Donor Work Group. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017;101(Suppl 8S):S1–S109.
- Published
- 2017
- Full Text
- View/download PDF
10. Scrub typhus: Atypical presentation in subhimalayan region
- Author
-
Chetan Sharda, Virendra Kumar, Anchal Sood, and Vivek S Guleria
- Subjects
medicine.medical_specialty ,business.industry ,CASE REPORT ,030231 tropical medicine ,General Medicine ,Eschar ,Scrub typhus ,medicine.disease ,Dermatology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,030212 general & internal medicine ,medicine.symptom ,Presentation (obstetrics) ,business - Published
- 2018
- Full Text
- View/download PDF
11. Deficiency of MicroRNA miR‐1954 Promotes Cardiac Remodeling and Fibrosis
- Author
-
Rakeshwar S. Guleria, Ana Paula Cremasco Takano, Sudhiranjan Gupta, and Valorie L. Chiasson
- Subjects
Cardiac fibrosis ,030204 cardiovascular system & hematology ,Molecular Cardiology ,Thrombospondin 1 ,Extracellular matrix ,0302 clinical medicine ,Fibrosis ,Medicine ,Original Research ,0303 health sciences ,Ventricular Remodeling ,microRNA ,Caspase 3 ,Angiotensin II ,High-Throughput Nucleotide Sequencing ,Organ Size ,Remodeling ,Up-Regulation ,bcl-2 Homologous Antagonist-Killer Protein ,cardiovascular system ,Cardiology and Cardiovascular Medicine ,Collagen Type IV ,Genetically modified mouse ,Cardiomegaly ,Mice, Transgenic ,transgenic mice ,Collagen Type I ,Sarcoplasmic Reticulum Calcium-Transporting ATPases ,Transforming Growth Factor beta1 ,03 medical and health sciences ,Animals ,S100 Calcium-Binding Protein A4 ,030304 developmental biology ,Interleukin-6 ,business.industry ,Myocardium ,fibrosis ,Connective Tissue Growth Factor ,Hypertrophy ,medicine.disease ,Actins ,Collagen Type I, alpha 1 Chain ,Disease Models, Animal ,MicroRNAs ,Collagen Type III ,Cancer research ,cardiac remodeling ,business - Abstract
Background Cardiac fibrosis occurs because of disruption of the extracellular matrix network leading to myocardial dysfunction. Angiotensin II (Ang II ) has been implicated in the development of cardiac fibrosis. Recently, micro RNA s have been identified as an attractive target for therapeutic intervention in cardiac pathologies; however, the underlying mechanism of micro RNA s in cardiac fibrosis remains unclear. Next‐generation sequencing analysis identified a novel characterized microRNA, miR‐1954, that was significantly reduced in AngII‐infused mice. The finding led us to hypothesize that deficiency of miR‐1954 triggers cardiac fibrosis. Methods and Results A transgenic mouse was created using α‐MHC (α‐myosin heavy chain) promoter and was challenged with AngII infusion. AngII induced cardiac hypertrophy and remodeling. The in vivo overexpression of miR‐1954 showed significant reduction in cardiac mass and blood pressure in AngII‐infused mice. Further analysis showed significant reduction in cardiac fibrotic genes, hypertrophy marker genes, and an inflammatory gene and restoration of a calcium‐regulated gene (Atp2a2 [ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2]; also known as SERCA 2), but no changes were observed in apoptotic genes. THBS 1 (thrombospondin 1) is indicated as a target gene for miR‐1954. Conclusions Our findings provide evidence, for the first time, that miR‐1954 plays a critical role in cardiac fibrosis by targeting THBS 1. We conclude that promoting the level of miR‐1954 would be a promising strategy for the treatment of cardiac fibrosis.
- Published
- 2019
- Full Text
- View/download PDF
12. Sustainable Production Systems for Agriculture Development in Mountains of Himachal Pradesh, India
- Author
-
Ashok Kumar, Atul Dogra, and J. S. Guleria
- Subjects
Geography ,Agriculture ,business.industry ,Agroforestry ,General Medicine ,Sustainable production ,business - Published
- 2016
- Full Text
- View/download PDF
13. Pneumocephalus Presenting as Sudden Thunderclap Headache
- Author
-
Vinod Kumar, Vivek S Guleria, Chetan Sharda, and Ajay K. Sharma
- Subjects
medicine.medical_specialty ,Subarachnoid hemorrhage ,business.industry ,subarachnoid hemorrhage ,Chronic otitis ,Chronic Suppurative Otitis Media ,Case Report ,General Medicine ,medicine.disease ,030218 nuclear medicine & medical imaging ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Pneumocephalus ,thunderclap headache ,Cranial cavity ,medicine ,business ,030217 neurology & neurosurgery ,Thunderclap headaches ,Sudden onset - Abstract
Pneumocephalus is a rare condition characterized by the presence of gas within the cranial cavity. This gas arises either from a trauma, tumor, surgical procedure, or occasionally from infection. Pneumocephalus secondary to chronic otitis media is an extremely rare phenomenon. We describe here a 70-year-old male, a known case of chronic suppurative otitis media who presented with sudden onset severe thunderclap headache and was eventually diagnosed as pneumocephalus.
- Published
- 2017
14. Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling
- Author
-
Rakeshwar S. Guleria, Sen Zhu, Kenneth M. Baker, and Jing Pan
- Subjects
medicine.drug_class ,Retinoic acid ,retinoic acid receptor ,lcsh:Medicine ,Review ,030204 cardiovascular system & hematology ,Pharmacology ,Retinoid X receptor ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Diabetic cardiomyopathy ,diabetic cardiomyopathy ,retinoic acid ,retinoid X receptor ,Medicine ,Retinoid ,Receptor ,030304 developmental biology ,0303 health sciences ,business.industry ,organic chemicals ,lcsh:R ,Lipid metabolism ,General Medicine ,medicine.disease ,3. Good health ,body regions ,Retinoic acid receptor ,Nuclear receptor ,chemistry ,embryonic structures ,diabetes mellitus ,business - Abstract
Diabetic cardiomyopathy (DCM), a significant contributor to morbidity and mortality in diabetic patients, is characterized by ventricular dysfunction, in the absence of coronary atherosclerosis and hypertension. There is no specific therapeutic strategy to effectively treat patients with DCM, due to a lack of a mechanistic understanding of the disease process. Retinoic acid, the active metabolite of vitamin A, is involved in a wide range of biological processes, through binding and activation of nuclear receptors: retinoic acid receptors (RAR) and retinoid X receptors (RXR). RAR/RXR-mediated signaling has been implicated in the regulation of glucose and lipid metabolism. Recently, it has been reported that activation of RAR/RXR has an important role in preventing the development of diabetic cardiomyopathy, through improving cardiac insulin resistance, inhibition of intracellular oxidative stress, NF-κB-mediated inflammatory responses and the renin-angiotensin system. Moreover, downregulated RAR/RXR signaling has been demonstrated in diabetic myocardium, suggesting that impaired RAR/RXR signaling may be a trigger to accelerate diabetes-induced development of DCM. Understanding the molecular mechanisms of retinoid receptors in the regulation of cardiac metabolism and remodeling under diabetic conditions is important in providing the impetus for generating novel therapeutic approaches for the prevention and treatment of diabetes-induced cardiac complications and heart failure.
- Published
- 2014
15. Alcohol induced epigenetic perturbations during the inflammatory stage of fracture healing
- Author
-
Christopher D. Chaput, Jason Brannen, Jing Pan, Rakeshwar S. Guleria, Robert A. Probe, Kenneth M. Baker, H. Wayne Sampson, and Vincent VanBuren
- Subjects
Male ,medicine.medical_specialty ,Microarray ,Inflammation ,Bone healing ,General Biochemistry, Genetics and Molecular Biology ,Epigenesis, Genetic ,Rats, Sprague-Dawley ,Internal medicine ,microRNA ,Gene expression ,medicine ,Animals ,RNA, Messenger ,Epigenetics ,Oligonucleotide Array Sequence Analysis ,Fracture Healing ,Messenger RNA ,Genome ,Ethanol ,business.industry ,Microarray analysis techniques ,Rats ,Surgery ,MicroRNAs ,Endocrinology ,medicine.symptom ,business - Abstract
It is well recognized by orthopedic surgeons that fractures of alcoholics are more difficult to heal successfully and have a higher incidence of non-union, but the mechanism of alcohol's effect on fracture healing is unknown. In order to give direction for the study of the effects of alcohol on fracture healing, we propose to identify gene expression and microRNA changes during the early stages of fracture healing that might be attributable to alcohol consumption. As the inflammatory stage appears to be the most critical for successful fracture healing, this paper focuses on the events at day three following fracture or the stage of inflammation. Sprague–Dawley rats were placed on an ethanol-containing or pair-fed Lieber and DeCarli diet for four weeks prior to surgical fracture. Following insertion of a medullary pin, a closed mid-diaphyseal fracture was induced using a Bonnarens and Einhorn fracture device. At three days' post-fracture, the region of the fracture calluses was harvested from the right hind-limb. RNA was extracted and microarray analysis was conducted against the entire rat genome. There were 35 genes that demonstrated significant increased expression due to alcohol consumption and 20 that decreased due to alcohol. In addition, the expression of 20 microRNAs was increased and six decreased. In summary, while it is recognized that mRNA levels may or may not represent protein levels successfully produced by the cell, these studies reveal changes in gene expression that support the hypothesis that alcohol consumption affects events involved with inflammation. MicroRNAs are known to modulate mRNA and these findings were consistent with much of what was seen with mRNA microarray analysis, especially the involvement of smad4 which was demonstrated by mRNA microarray, microRNA and polymerase chain reaction.
- Published
- 2011
- Full Text
- View/download PDF
16. Ceftriaxone induced drug rash with eosinophilia and systemic symptoms
- Author
-
Vivek S Guleria, Nardeep Naithani, Shaman Gill, and M. K. Dhillon
- Subjects
medicine.medical_specialty ,medicine.drug_class ,Antibiotics ,Allopurinol ,lcsh:RS1-441 ,Case Report ,Pharmacy ,lcsh:Pharmacy and materia medica ,Drug rash with eosinophilia and systemic symptom ,Eosinophilia ,medicine ,Drug rash ,Pharmacology (medical) ,General Pharmacology, Toxicology and Pharmaceutics ,integumentary system ,business.industry ,Ceftriaxone ,medicine.disease ,Dermatology ,Rash ,Pneumonia ,Immunology ,Transaminitis ,medicine.symptom ,business ,medicine.drug - Abstract
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a drug reaction commonly occurring in association with aromatic anticonvulsants and allopurinol. It is characterized by triad of fever, skin eruption, and systemic involvement. DRESS is rare with beta-lactam antibiotics and even rarer with ceftriaxone. We describe a case of pneumonia who developed ceftriaxone-induced rash, bicytopenia, eosinophilia, transaminitis and was eventually diagnosed and managed successfully as a case of DRESS.
- Published
- 2014
17. All that seems sepsis is not sepsis
- Author
-
Vivek S Guleria, Subramanian Shankar, Velu Nair, and Prabhat Chauhan
- Subjects
medicine.medical_specialty ,business.industry ,Organ dysfunction ,Case Report ,Critical Care and Intensive Care Medicine ,Catastrophic antiphospholipid syndrome ,medicine.disease ,sepsis ,Sepsis ,Systemic inflammatory response syndrome ,systemic lupus erythematosus ,Medicine ,Presentation (obstetrics) ,medicine.symptom ,business ,Intensive care medicine ,Severe sepsis - Abstract
Catastrophic antiphospholipid antibody syndrome (CAPS) resembles severe sepsis in its acute presentation, with features of systemic inflammatory response syndrome (SIRS) leading to multiple organ dysfunction. Infections are the best known triggers of CAPS. This emphasizes the need for early diagnosis and aggressive treatment as the mortality is as high as 50%. We present a 42-year-old woman who developed SIRS postoperatively and was eventually diagnosed as CAPS.
- Published
- 2013
- Full Text
- View/download PDF
18. Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap
- Author
-
Puneet Saxena, Shankar Subramanian, Pradeep Singh, and Vivek S Guleria
- Subjects
Pulmonary and Respiratory Medicine ,lcsh:RC705-779 ,Orthopnea ,Pathology ,medicine.medical_specialty ,integumentary system ,business.industry ,Shrinking lung syndrome ,Case Report ,lcsh:Diseases of the respiratory system ,medicine.disease ,Dermatology ,Therapeutic modalities ,Scleroderma ,Pathogenesis ,systemic lupus erythematosus ,immune system diseases ,medicine ,Pleuritic chest pain ,medicine.symptom ,Complication ,business ,skin and connective tissue diseases ,scleroderma shrinking lung syndrome - Abstract
Shrinking lung syndrome (SLS) is a infrequently reported manifestation of systemic lupus erythematosus (SLE). Reported prevalence of SLS is about 0.5% in SLE patients. Pathogenesis is not fully understood and different therapeutic modalities have been employed with variable results, as only 77 cases of SLS have been documented in literature. SLS in SLE-Scleroderma overlap has not been reported yet. We report a patient of SLE - scleroderma overlap presenting with dyspnea, intermittent orthopnea and pleuritic chest pain. Evaluation revealed elevated hemidiaphragms and severe restrictive defect. She was eventually diagnosed as a case of SLS. This case report is a reminder to the medical fraternity that SLS although a rare complication must be thought of in the special subset of patients of SLE having respiratory symptoms.
- Published
- 2014
19. Deep Vein Thrombosis after Coronary Angiography
- Author
-
A K Sood, T. Rana, Vivek S Guleria, and M. K. Dhillon
- Subjects
Coronary angiography ,medicine.medical_specialty ,anticoagulants ,lcsh:Diseases of the circulatory (Cardiovascular) system ,medicine.diagnostic_test ,business.industry ,Incidence (epidemiology) ,Deep vein ,Angiography ,medicine.disease ,Thrombosis ,medicine.anatomical_structure ,lcsh:RC666-701 ,medicine ,Radiology ,cardiovascular diseases ,business ,Complication ,Venous thromboembolism ,DVT - Abstract
Deep vein thrombosis (DVT) is a rare but potentially serious complication of coronary angiography (CAG), incidence being just 0.05%. Only a few clinical cases of DVT after diagnostic transfemoral catheterization have been reported. Here, we describe the case of a 54-year-old woman who developed significant DVT after CAG without venous thromboembolism (VTE) and, which was treated with anticoagulants.
- Published
- 2015
20. Ureteric Complications of Renal Transplantation: The Impact of the Double J Stent and the Anterior Extravesical Ureteroneocystostomy
- Author
-
H.C. Irving, R. Chahal, C. G. Newstead, Stephen Pollard, J.P.A. Lodge, S. Guleria, and Sanjeev Madaan
- Subjects
medicine.medical_specialty ,Percutaneous ,medicine.medical_treatment ,Urinary system ,urologic and male genital diseases ,Postoperative Complications ,Ureter ,medicine ,Humans ,Ureterostomy ,Retrospective Studies ,Transplantation ,Kidney ,business.industry ,Incidence ,Stent ,Kidney Transplantation ,Surgery ,Cystostomy ,surgical procedures, operative ,medicine.anatomical_structure ,Double j stent ,Stents ,business ,Complication ,Ureteral Obstruction - Abstract
The urological complications of renal transplantation are well documented. In 1990, our experience of 507 consecutive renal transplants using the Leadbetter-Politano technique, which was unsplinted in the vast majority of patients, had a ureteric complication rate of 7.7%. Here, we report the long-term incidence and management of our ureteric complications in 1186 consecutive renal transplants done over the following 11 years using an extravesical onlay stented ureteroneocystostomy. We report a considerable reduction in the urological complications of renal transplantation to 3.8%. Furthermore, we were able to use percutaneous radiological techniques to salvage the majority (84.7%) of ureteric complications. Recourse to surgery was required rarely but enabled salvage of all treatment failures.
- Published
- 2005
- Full Text
- View/download PDF
21. The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma
- Author
-
Jan Einhorn, Mark P. Macfarlane, Claudia A. Seipp, Richard L. White, Donald E. White, Anshu S. Guleria, Steven A. Rosenberg, and James Chih-Hsin Yang
- Subjects
Prothrombin time ,Cancer Research ,medicine.medical_specialty ,Leukopenia ,Lymphocytosis ,medicine.diagnostic_test ,Anemia ,business.industry ,Cancer ,medicine.disease ,Gastroenterology ,Surgery ,Oncology ,Renal cell carcinoma ,Internal medicine ,medicine ,Carcinoma ,Coagulopathy ,medicine.symptom ,business - Abstract
Background. High dose interleukin-2 (IL-2) has been found to produce durable antitumor responses in some patients, benefiting most greatly those patients with melanoma and renal cell carcinoma. In this paper, the hematologic toxicity and changes resulting from high dose IL-2 alone administered by intravenous bolus are discussed. Methods. One hundred ninety-nine consecutive patients treated with high dose IL-2 alone from January 1, 1988 to December 31, 1992 were included in this study. All patients had a diagnosis of metastatic melanoma or metastatic renal cell carcinoma and were treated at the National Cancer Institute (Bethesda, MD). Results. Anemia, requiring erythrocyte transfusions, occurred in 14% of all treatment courses, with a median of two units of erythrocytes transfused. Severe leukopenia (
- Published
- 1995
- Full Text
- View/download PDF
22. Abstract P6-02-11: When needles are needed
- Author
-
A Peterkin, S Guleria, M von Euler-Chelpin, A-V Lænkholm, Ilse Vejborg, and Elsebeth Lynge
- Subjects
Gynecology ,Breast biopsy ,Cancer Research ,education.field_of_study ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,General surgery ,Population ,Absolute risk reduction ,Cancer ,medicine.disease ,Screening programme ,Breast cancer ,Oncology ,Biopsy ,medicine ,Mammography ,education ,business - Abstract
Background Women with positive screening mammograms but negative at assessment (false-positive) are referred back to routine screening assuming that they have an average risk of breast cancer. However in a long-term follow-up of women with false-positive screening mammography we found that these women had in fact an excess risk of breast cancer later in life; RR=1.67(von Euler-Chelpin et al, JNCI 2012). This finding has later been supported by Castells et al.(Cancer Epidemiol, 2013). Furthermore, we studied the breast cancer cases in false-positive women and found that 26% of the cases were misclassified and were in fact true positives. However, even correction for misclassification, the false-positive women in our study remained at an excess breast cancer risk. At the same time, it was clear that, in the later periods of our study, when more modern techniques were used, the rate of misclassification decreased (von Euler-Chelpin et al, Cancer Epidemiol., 2014). Over time there have been changes both in the imaging and biopsy techniques. We used data from an organised screening programme in Denmark. Since its start in 1991, needle biopsies have been performed on all palpable solid lesions and on all uncertain, suspicious or malignant findings. In the very beginning fine needle aspiration cytology (FNAC) was used, later to be replaced by needle core biopsies in the majority of cases. Since 2002, suspicious micro-calcifications and impalpable mammographic findings not found by ultrasound have been examined using stereotactic needle core biopsy and later with vacuum-assisted breast biopsy as a replacement for surgical biopsy. To have a needle breast biopsy taken is a psychological burden on the woman. To minimize the harms and maximize the benefits is at the core of developing medical care. We therefore mapped the use of needle biopsies over time in a long-standing, organised screening programme. Method: We used data from the population-based screening mammography program in Copenhagen, Denmark. The programme has a database including personal records on demographic data, date of invitation, data of screening, and test results,1998-2013. Data from the Mammography Register were linked to the Danish Pathology Register (for biopsy procedures). Results: A total of 208 500 screens were included in the study. The rate of recall for assessment ranged between 1.7-3.2% of screened women with a mean of 2.4. The false-positive rate ranged between 1.0-2.5% with a mean of 1.6%. In 1998, 56% of all recalled women had a biopsy taken, which by 2013 had risen to 74% (using two-year smoothing). In proportion of all screens, the biopsy rate was 1.9% in 1998/99 which then fell to 0.7% in 2005/06 and the rose again 2.0% in 2012/13. In 1998, 59% of the biopsies were fine-needle aspiration cytology (FNAC) which by 2013 was only used in 11% of the cases, and replaced by core biopsies, ultrasound or stereotactic guided. Conclusion While the recall rate, as well as the false-positive rate, has been fairly stable during the study period the use of needle core biopsies has had a u-shaped development and has intensified in the later years. Citation Format: von Euler-Chelpin M, Vejborg I, Lænkholm A-V, Guleria S, Peterkin A, Lynge E. When needles are needed. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P6-02-11.
- Published
- 2016
- Full Text
- View/download PDF
23. An Atypical Case of Chiari II Malformation Mimicking Partial Rhombencephalosynapsis
- Author
-
Teresa G. Kelly, Mohit Maheshwari, S. Guleria, and H.D. Segall
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,business.industry ,embryonic structures ,Medicine ,Radiology, Nuclear Medicine and imaging ,Hindbrain ,Neurology (clinical) ,General Medicine ,Anatomy ,Abnormality ,business ,nervous system diseases - Abstract
Partial rhombencephalosynapsis in the presence of Chiari II malformation has been proposed as a “new abnormality of the hindbrain and spine“. We describe a case of Chiari II malformation with imaging features mimicking partial rhombencephalosynapsis. Our case demonstrates how the imaging findings of Chiari II malformation can be confused with the above entity and highlights the differentiating features to help radiologists make an accurate diagnosis.
- Published
- 2012
24. Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma
- Author
-
Richard L. White, Suzanne L. Topalian, Mark P. Macfarlane, Jan Einhorn, Jeffrey S. Weber, David R. Parkinson, Seth M. Steinberg, Donald E. White, A S Guleria, and James Chih-Hsin Yang
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Skin Neoplasms ,Adolescent ,medicine.medical_treatment ,Urology ,Drug Administration Schedule ,Blood Urea Nitrogen ,chemistry.chemical_compound ,Oliguria ,Humans ,Medicine ,Child ,Carcinoma, Renal Cell ,Melanoma ,Aged ,Creatinine ,business.industry ,Incidence (epidemiology) ,Cancer ,Middle Aged ,medicine.disease ,Kidney Neoplasms ,Nephrectomy ,Surgery ,Discontinuation ,Oncology ,chemistry ,Interleukin-2 ,Female ,Kidney Diseases ,medicine.symptom ,business ,Weight gain - Abstract
PURPOSE To describe the incidence and management of renal dysfunction associated with the use of high-dose interleukin-2 (IL-2) (as is currently approved) in the treatment of cancer patients. PATIENTS AND METHODS One hundred ninety-nine consecutive patients with metastatic renal carcinoma or melanoma were treated with intravenous bolus infusions of IL-2 alone (720,000 IU/kg) every 8 hours. RESULTS Patients received 310 courses (589 cycles) of therapy and most experienced oliguria, hypotension, and weight gain; 13% of cycles were discontinued due to increased serum creatinine levels. Creatinine values (mean pretherapy, 1.2 mg/dL) increased during therapy and peaked (mean, 2.7 mg/dL) approximately 1 day after discontinuation of the second cycle of IL-2. Off therapy, toxicities reversed promptly and creatinine values returned to baseline. Higher peak creatinine values occurred in patients with renal carcinoma (v melanoma), older patients, males (v females), and those who had undergone prior nephrectomy. These same patient subsets received fewer doses of IL-2, but clinical responses were not associated with creatinine values or number of IL-2 doses administered. Urinalyses showed the appearance of protein, bilirubin, RBCs, WBCs, and granular casts during therapy, which cleared completely on follow-up evaluation. CONCLUSION High-dose IL-2 can be safely administered to cancer patients. The associated renal dysfunction is transient and without evidence of intrinsic long-term renal damage. Practical guidelines for patient management have been identified.
- Published
- 1994
- Full Text
- View/download PDF
25. Experience with schistosomiasis in renal transplantation
- Author
-
Mitchell Edson, Jimmy A. Light, Ahmed Ali, Anshu S. Guleria, Nabil Khawand, Timothy C. Mccanty, and Korb S
- Subjects
Adult ,Male ,medicine.medical_specialty ,Urology ,Urinary system ,Saudi Arabia ,Schistosomiasis ,Sudan ,Schistosomiasis haematobia ,Internal medicine ,medicine ,Humans ,Kidney transplantation ,Schistosoma haematobium ,Urinary bladder ,biology ,medicine.diagnostic_test ,business.industry ,Urinary Bladder Diseases ,Cystoscopy ,Middle Aged ,medicine.disease ,biology.organism_classification ,Kidney Transplantation ,Surgery ,Transplantation ,medicine.anatomical_structure ,District of Columbia ,Kidney Failure, Chronic ,Urinary bladder disease ,business - Abstract
Schistosomiasis involving the urinary tract has only occasionally been reported in North American literature and rarely from American hospital experience. Chronic infection may result in numerous abnormalities of the urinary tract which may interfere with the function of a transplanted kidney. Our institution has performed a number of renal transplants in patients who are from countries where schistosomiasis is endemic. Six patients in our group had evidence of schistosomal disease during their pretransplant evaluation and were appropriately treated. None of these patients had postoperative complications attributable to the schistosomal disease. We recommend that all patients who are from areas where urinary schistosomiasis is endemic undergo a cystoscopic examination and bladder biopsies in addition to the routine pretransplant urologic evaluation.
- Published
- 1992
- Full Text
- View/download PDF
26. Contents Vol. 83, 1999
- Author
-
Emilio Antonio Francischetti, Godelieve Hellemans, Rieko Nagaoka, Giuseppe D'Amico, Paul Proost, Hikaru Koide, Hein Van Poppel, Sang Ho Lee, Masahiro Okazaki, Hiroyuki Ohmuro, Hiroshi Tanaka, Chieko Hamada, Enyu Imai, Aimon Laohapaibul, S.C. Tiwari, Kunimi Maeda, M. Myśliwiec, Hiroaki Kato, Rodolfo Zavala, Okay Vural, Jaime Urcia, A. Soumillion, Maria Elena Hurtado, Cormac P. Breen, Kenichi Kano, Yasuhiko Tomino, S. Guleria, Kazunari Kaneko, Yoshitaka Isaka, R. Pawlak, Thumronkprawat Cherdkiattikul, Akihiko Osajima, Inah Maria Drummond Pecly, Ryang Hwa Lee, Fatih Bulucu, S.N. Mehta, Osamu Arisaka, Chifuyu Ushiyama, Ulrich Graefe, Luc Baert, Grant T. Robinson, S.K. Agarwal, Carmen Asato, Kazuhiro Sakamoto, Klaus Langer, Raidt H, Jo Van Damme, J.S. Małyszko, Sachio Ito, Yasuhito Uezono, Şeref Demirkaya, Prasit Futrakul, D. Bhowmick, Yasuhide Nakashima, Marc De Ley, Mitsumine Fukui, Yoshiyuki Ohtomo, Chris S. Stromquist, Reiner Riezler, Shigeki Tomita, Fikri Kocabalkan, A. Azzadin, Richard J. Johnson, Yuichiro Yamashiro, J. Małyszko, Mi Young Park, A.J. Nicholls, Abdias Hurtado, Elizabeth Escudero, S.C. Dash, Mark H. Wener, Yoshihiko Ueda, Isao Ebihara, Rajanee Sensirivatana, Iain C. Macdougall, Bernhard F. Henning, P. Anthony, Tsukasa Nakamura, S.C. Satchell, Walter Zidek, Futoshi Izumi, Narisa Futrakul, Noriaki Shimada, Tamotsu Ando, Sonia de la Cruz, S. Gupta, Ole Torffvit, Peter A. Andrews, Shingo Suzuki, W. Buczko, Fagundes Vg, Sithvudh Futrakul, Martin Tepel, Masahito Tamura, Takeshi Suda, Yosuke Oishi, Bengt Rippe, T. Wollny, and Jin Sup Jung
- Subjects
Traditional medicine ,business.industry ,Medicine ,business - Published
- 1999
- Full Text
- View/download PDF
27. Completion of free human papillomavirus (HPV) vaccination series at an urban public hospital
- Author
-
Ashlesha Patel, K. Swanson, Lindsay Zimmerman, S. Guleria, and K. Stempinski
- Subjects
Gynecology ,medicine.medical_specialty ,Reproductive Medicine ,business.industry ,Family medicine ,Public hospital ,medicine ,Obstetrics and Gynecology ,Hpv vaccination ,Human papillomavirus ,business - Published
- 2015
- Full Text
- View/download PDF
28. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report
- Author
-
T. Rana, Chetan Sharda, A K Sood, and Vivek S Guleria
- Subjects
Male ,Erythema ,medicine.drug_class ,medicine.medical_treatment ,oxcarbazepine ,Pharmacology ,Drug Watch ,Epilepsy ,toxic epidermal necrolysis ,medicine ,Anticholinergic ,Maculopapular rash ,Humans ,Pharmacology (medical) ,Oxcarbazepine ,business.industry ,Carbamazepine ,Middle Aged ,Stevens–Johnson syndrome ,medicine.disease ,Toxic epidermal necrolysis ,Anticonvulsant ,Stevens-Johnson Syndrome ,Anticonvulsants ,medicine.symptom ,business ,medicine.drug - Abstract
Carbamazepine, is well known to cause Stevens–Johnson syndrome and toxic epidermal necrolysis(TEN). Oxcarbazepine, a 10-keto analog of carbamazepine, is an anticholinergic, anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy. Its efficacy is similar to carbamazepine but allergic reactions and enzyme induction is low. We describe a case of oxcarbazepine induced TEN, who presented with erythematous ulcerative maculopapular rash.
- Published
- 2015
- Full Text
- View/download PDF
29. Ceftriaxone-induced hemolysis
- Author
-
Nitin Sharma, Velu Nair, Vivek S Guleria, and Sagar Amitabh
- Subjects
Blood transfusion ,medicine.drug_class ,medicine.medical_treatment ,Antibiotics ,Drug Watch ,Immune Hemolytic Anemia ,medicine ,Humans ,Pharmacology (medical) ,Blood Transfusion ,Adverse effect ,Pharmacology ,business.industry ,Middle Aged ,medicine.disease ,Hemolysis ,Discontinuation ,Anti-Bacterial Agents ,ceftriaxone ,Pneumonia ,Anesthesia ,Ceftriaxone ,Female ,hemolysis ,business ,ADRs ,medicine.drug - Abstract
Immune hemolytic anemia is a rare adverse effect of ceftriaxone, a third-generation cephalosporin, which is a commonly used antibiotic. We describe a 60-years-old lady, a case of community-acquired pneumonia, who developed severe hemolysis after the first dose of ceftriaxone. Her hemoglobin dropped from 9.6 g /dl to 5.5 g /dl. However, she improved after discontinuation of the drug and blood transfusion. This report serves as a reminder to medical fraternity that life-threatening hemolysis can rarely follow administration of ceftriaxone.
- Published
- 2013
30. 020 Effect of renal transplant on coronary artery calcification
- Author
-
Dipankar Bhowmik, Sandeep Aggarwal, Gurpreet Singh Gulati, SK Aggarwal, Supriya Sharma, S. Guleria, S.K. Mahajan, Priya Jagia, Imtiakum, GS Bora, and Sanjay Gupta
- Subjects
Transplantation ,medicine.medical_specialty ,Renal transplant ,business.industry ,Internal medicine ,Coronary artery calcification ,Cardiology ,medicine ,business - Published
- 2010
- Full Text
- View/download PDF
31. Multicentric renal cell carcinoma in a transplanted kidney
- Author
-
A. S. Guleria, Jimmy A. Light, Seyed R. Ghasemian, and T M Sasaki
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,Transplanted kidney ,Nephrectomy ,Renal cell carcinoma ,Risk Factors ,Carcinoma ,Medicine ,Humans ,Carcinoma, Renal Cell ,Transplantation ,Kidney ,business.industry ,Immunosuppression ,DNA, Neoplasm ,medicine.disease ,Kidney Transplantation ,Kidney Neoplasms ,medicine.anatomical_structure ,business ,Complication ,Kidney disease - Published
- 1997
32. Is minimally invasive donor nephrectomy the future?
- Author
-
S. Guleria
- Subjects
Transplantation ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Endoscopic surgery ,Nephrectomy ,Living donor ,Surgery ,Tissue and Organ Harvesting ,medicine ,Humans ,Minimally Invasive Surgical Procedures ,Organ donation ,Laparoscopy ,business - Published
- 2003
- Full Text
- View/download PDF
33. High Frequency of CCR5 and CCR2 Expressing T Cells and Its Association with Acute Renal Allograft Rejection
- Author
-
S Gupta, A. K. Dinda, Dipendra Kumar Mitra, S. Guleria, and Ankit Saxena
- Subjects
Transplantation ,CCR2 ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Renal allograft ,business ,Gastroenterology - Published
- 2012
- Full Text
- View/download PDF
34. CLINICAL RELEVANCE OF CYTOKINE GENE POLYMORPHISM ON POST TRANSPLANT RENAL ALLOGRAFT SURVIVAL
- Author
-
G. Kaur, Jamshaid A. Siddiqui, Narinder K. Mehra, Dipankar Bhowmik, and S. Guleria
- Subjects
Transplantation ,business.industry ,Immunology ,Renal allograft ,Medicine ,Clinical significance ,Cytokine genes ,business ,Post transplant - Published
- 2010
- Full Text
- View/download PDF
35. THE QUALITY OF LIFE OF LIVE RELATED DONOR IN INDIA
- Author
-
Virinder Kumar Bansal, Ashwani Gupta, Agarwal Sk, S. K. Reddy, Supriya Gupta, R. Sagar, Dipankar Bhowmik, Supriya D. Mahajan, and S. Guleria
- Subjects
Transplantation ,Business ,Socioeconomics - Published
- 2010
- Full Text
- View/download PDF
36. TO IDENTIFY THE RISK FACTORS FOR POST TRANSPLANTATION NEW ONSET DIABETES MELLITUS
- Author
-
Agarwal Sk, Dipankar Bhowmik, N. Gupta, Sanjay K. Agarwal, Nidhi Tandon, S. Guleria, GS Bora, and Supriya Gupta
- Subjects
Transplantation ,Pediatrics ,medicine.medical_specialty ,New onset diabetes ,business.industry ,Medicine ,business ,Post transplant - Published
- 2010
- Full Text
- View/download PDF
37. 414 Development of novel steroidal oxime-ethers for breast cancer therapy
- Author
-
R.W. Hartmann, A. Palusczak, S. Thota, R. Bansal, and S. Guleria
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Cancer ,medicine.disease ,Oxime ,chemistry.chemical_compound ,Breast cancer ,chemistry ,Internal medicine ,medicine ,business - Published
- 2010
- Full Text
- View/download PDF
38. The impact of protocol biopsies in a live related renal trasplant program using tacrolimus based immunosuppression
- Author
-
Ashwani Gupta, Sanjay Gupta, S. Guleria, Virinder Kumar Bansal, Narinder K. Mehra, Dipankar Bhowmik, S.K. Mahajan, A Panigarhi, S.K. Agarwal, Amit K. Dinda, Swasti Tiwari, and S. Jain
- Subjects
Protocol (science) ,Transplantation ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Urology ,medicine ,Immunosuppression ,business ,Tacrolimus - Published
- 2009
- Full Text
- View/download PDF
39. To assess the impact of protocol biopsies in tacrolimus versus cyclosporine in a live related renal transplant program
- Author
-
Sanjay Gupta, Ashwani Gupta, A Panigarhi, Dipankar Bhowmik, S. Guleria, S.K. Mahajan, S.K. Agarwal, S. Jain, Swasti Tiwari, Narinder K. Mehra, Virinder Kumar Bansal, and Amit K. Dinda
- Subjects
Protocol (science) ,Transplantation ,medicine.medical_specialty ,Renal transplant ,business.industry ,Urology ,medicine ,business ,Tacrolimus - Published
- 2009
- Full Text
- View/download PDF
40. Is Laparoscopic donor nephrectomy really the way ahead?
- Author
-
Swasti Tiwari, Sanjay Gupta, S.K. Mahajan, D Bhownik, S. Guleria, Sandeep Aggarwal, Vemuru Sunil K Reddy, S. Jain, Rajesh Kumar, and S.K. Agarwal
- Subjects
Transplantation ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,General surgery ,Medicine ,business ,Nephrectomy - Published
- 2009
- Full Text
- View/download PDF
41. Transplant renal artery aneurysm following venous patch repair of a traction injury to the renal artery
- Author
-
J.P.A. Lodge, Niaz Ahmad, S. Guleria, Stephen Pollard, and C. G. Newstead
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Adolescent ,Surgical anastomosis ,Postoperative Complications ,Renal Artery ,Aneurysm ,medicine.artery ,medicine ,Humans ,Renal artery ,Transplantation ,Kidney ,business.industry ,medicine.disease ,Kidney Transplantation ,Internal iliac artery ,Tissue Donors ,Surgery ,Radiography ,medicine.anatomical_structure ,Nephrology ,Renal vein ,business ,Kidney disease - Published
- 1998
- Full Text
- View/download PDF
42. Subject Index Vol. 83, 1999
- Author
-
Yasuhito Uezono, Klaus Langer, Prasit Futrakul, Jo Van Damme, Jin Sup Jung, Hiroshi Tanaka, Osamu Arisaka, Paul Proost, Maria Elena Hurtado, Yasuhiko Tomino, S. Guleria, Hikaru Koide, Enyu Imai, S.C. Satchell, Tamotsu Ando, Godelieve Hellemans, Chieko Hamada, Elizabeth Escudero, Mark H. Wener, M. Myśliwiec, Abdias Hurtado, A. Soumillion, Okay Vural, J.S. Małyszko, Giuseppe D'Amico, Bengt Rippe, Cormac P. Breen, Akihiko Osajima, Yoshihiko Ueda, Narisa Futrakul, S.K. Agarwal, Emilio Antonio Francischetti, Futoshi Izumi, Reiner Riezler, A.J. Nicholls, Mi Young Park, Yoshitaka Isaka, S.C. Tiwari, Mitsumine Fukui, P. Anthony, Yasuhide Nakashima, D. Bhowmick, Hein Van Poppel, T. Wollny, Ole Torffvit, Shigeki Tomita, Fikri Kocabalkan, Hiroaki Kato, Hiroyuki Ohmuro, Takeshi Suda, Peter A. Andrews, Marc De Ley, A. Azzadin, S.N. Mehta, Yuichiro Yamashiro, Walter Zidek, Jaime Urcia, J. Małyszko, Martin Tepel, Kazunari Kaneko, Iain C. Macdougall, R. Pawlak, Thumronkprawat Cherdkiattikul, Şeref Demirkaya, Virginia Genelhu de Abreu Fagundes, Sachio Ito, Tsukasa Nakamura, Rieko Nagaoka, Kunimi Maeda, Sang Ho Lee, Carmen Asato, Ulrich Graefe, Shingo Suzuki, Raidt H, Richard J. Johnson, Inah Maria Drummond Pecly, Masahiro Okazaki, Aimon Laohapaibul, Sithvudh Futrakul, Bernhard F. Henning, Rodolfo Zavala, Yoshiyuki Ohtomo, Chris S. Stromquist, Masahito Tamura, W. Buczko, Isao Ebihara, Grant T. Robinson, S.C. Dash, Yosuke Oishi, Rajanee Sensirivatana, Ryang Hwa Lee, Chifuyu Ushiyama, Luc Baert, Kenichi Kano, Fatih Bulucu, Kazuhiro Sakamoto, Noriaki Shimada, Sonia de la Cruz, and S. Gupta
- Subjects
Index (economics) ,business.industry ,Statistics ,Medicine ,Subject (documents) ,business - Published
- 1999
- Full Text
- View/download PDF
43. Pulmonary diffusing capacity at high altitude
- Author
-
S B Roy, P K Sethi, J S Guleria, and J N Pande
- Subjects
Adult ,Carbon Monoxide ,medicine.medical_specialty ,Time Factors ,Physiology ,business.industry ,Acclimatization ,Altitude ,Pulmonary Diffusing Capacity ,Body Weight ,Smoking ,India ,Effects of high altitude on humans ,Body Height ,Hemoglobins ,Spirometry ,Physiology (medical) ,Internal medicine ,medicine ,Cardiology ,Humans ,Hypoxia ,business - Published
- 1971
- Full Text
- View/download PDF
44. Glucocorticoid Receptors in Bronchoalveolar Lavage Fluid in Sarcoidosis
- Author
-
Kusum Verma, Surender K. Sharma, Kailappa Murugesan, Jagdev S. Guleria, Urmil Verma, and Pande Jn
- Subjects
Pulmonary and Respiratory Medicine ,Bronchus ,Pathology ,medicine.medical_specialty ,Lung ,medicine.diagnostic_test ,business.industry ,medicine.drug_class ,Lymphocyte ,respiratory system ,Critical Care and Intensive Care Medicine ,medicine.disease ,respiratory tract diseases ,medicine.anatomical_structure ,Bronchoalveolar lavage ,Glucocorticoid receptor ,Immunology ,medicine ,Corticosteroid ,Sarcoidosis ,Cardiology and Cardiovascular Medicine ,business ,Glucocorticoid ,medicine.drug - Abstract
Glucocorticoid receptor (GR) content was measured in bronchoalveolar lavage fluid (BALF) cells of 20 untreated patients with sarcoidosis. A significantly higher (p
- Published
- 1988
- Full Text
- View/download PDF
45. Role of radio-aerosol and perfusion lung imaging in early detection of chronic obstructive lung disease
- Author
-
Abhimanyu Garg, J. S. Guleria, J. N. Pande, and Gopinath Pg
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Physical examination ,Respiratory physiology ,Pulmonary function testing ,Isotopes of technetium ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Lung Diseases, Obstructive ,Respiratory system ,Radionuclide Imaging ,Technetium Tc 99m Aggregated Albumin ,Serum Albumin ,Aged ,Lung ,medicine.diagnostic_test ,business.industry ,Technetium ,General Medicine ,Middle Aged ,respiratory system ,medicine.disease ,Obstructive lung disease ,Respiratory Function Tests ,respiratory tract diseases ,Perfusion ,medicine.anatomical_structure ,Radiology ,business - Abstract
The efficacy of radio-aerosol and perfusion lung imaging in the early detection of chronic obstructive lung disease was evaluated in 38 subjects. The subjects included 5 non-smokers, 21 smokers with minimal or no respiratory symptoms and 12 patients with chronic obstructive lung disease. Each subject consented to a respiratory questionnaire, detailed physical examination, chest X-ray examinations, detailed pulmonary function tests and 99mTc-radio aerosol-inhalation lung imaging. Perfusion lung imaging with 99mTc-labelled macroaggregated albumin was performed in 22 subjects. A significant correlation (P less than 0.001) was observed between the degree of abnormalities on radio-aerosol imaging and pulmonary function tests (PFTs) including forced expiratory volume in 1 s, maximum mid-expiratory flow rate and mean transit time analysis. Abnormal radio-aerosol patterns and deranged PFTs were observed in 21 subjects each. Of 21 subjects with abnormal radioaerosol pattern 8 had normal PFTs. Of 21 subjects with abnormal PFTs 8 had normal aerosol images. Aerosol lung images and PFTs were abnormal more frequently than perfusion lung images. The results suggest that radio-aerosol lung imaging is as sensitive an indicator as PFTs for early detection of chronic obstructive lung disease and can be usefully combined with PFTs for early detection of alteration in pulmonary physiology in smokers.
- Published
- 1983
- Full Text
- View/download PDF
46. Heart and lung functions in swimmers and nonathletes during growth
- Author
-
J. S. Guleria, M. R. Becklake, D. V. Bates, and G. M. Andrew
- Subjects
Male ,Adolescent ,Physiology ,Physical Exertion ,Vital Capacity ,Growth ,Bioinformatics ,Text mining ,Oxygen Consumption ,Sex Factors ,Physiology (medical) ,Medicine ,Humans ,Cardiac Output ,Child ,Lung ,Swimming ,Carbon Monoxide ,Physical Education and Training ,business.industry ,Computers ,Respiration ,Age Factors ,Heart ,Body Height ,Oxygen ,medicine.anatomical_structure ,Spirometry ,Pulmonary Diffusing Capacity ,Female ,business - Published
- 1972
47. Effect of breathing cold air on pulmonary mechanics in normal man
- Author
-
O P Malhotra, J. R. Talwar, J S Guleria, and J N Pande
- Subjects
Adult ,Male ,medicine.medical_specialty ,Physiology ,Poison control ,Suicide prevention ,Occupational safety and health ,Physiology (medical) ,Injury prevention ,Methods ,Medicine ,Humans ,Lung Compliance ,Pulmonary mechanics ,business.industry ,Air ,Respiration ,Cold air ,Human factors and ergonomics ,Middle Aged ,medicine.disease ,Cold Temperature ,Spirometry ,Emergency medicine ,Breathing ,Respiratory Physiological Phenomena ,Medical emergency ,business - Published
- 1969
48. Renovascular hypertension resulting from nonspecific aortoarteritis in children: Midterm results of percutaneous transluminal renal angioplasty and predictors of restenosis
- Author
-
A. K. Saxena, Deepak Thatai, Mira Rajani, Kothari Ss, S Guleria, and Sanjay Sharma
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Blood Pressure ,Renal Artery Obstruction ,Aortography ,Renovascular hypertension ,Renal Artery ,Restenosis ,Recurrence ,Angioplasty ,Internal medicine ,medicine.artery ,medicine ,Humans ,Life Tables ,Radiology, Nuclear Medicine and imaging ,Renal artery ,Child ,Vascular Patency ,Retrospective Studies ,business.industry ,Vascular disease ,General Medicine ,medicine.disease ,Takayasu Arteritis ,Surgery ,Stenosis ,Hypertension, Renovascular ,Blood pressure ,medicine.anatomical_structure ,Child, Preschool ,Cardiology ,Female ,business ,Angioplasty, Balloon ,Artery - Abstract
Nonspecific aortoarteritis is a major cause of renovascular hypertension in children. Stenosis of the renal artery is usually long and begins at the origin of that artery. We retrospectively studied the midterm results of angioplasty during treatment and defined the predictors of restenosis in 40 stenoses in 24 children.All patients had clinically inactive disease and hemodynamically significant stenosis causing hypertension. Midterm results were analyzed by the life table method. The effect of clinical, angiographic, and technical factors on the restenosis rate was tested by the Kaplan-Meir survival method.Technical success was obtained without complications in 38 (95%) of the lesions in 22 (92%) of the patients. The stenosis decreased from 89 +/- 7% to 11 +/- 12%, the pressure gradient fell from 97 +/- 27 to 10 +/- 10 mm Hg, and blood pressure decreased from 174 +/- 14/112 +/- 11 to 141 +/- 13/88 +/- 11 mm Hg (p.001). Clinical benefit was seen in all patients with technically successful angioplasty. During the follow-up period (33 +/- 22 months), restenosis was seen in eight lesions (20%). The predicted cumulative patency rate at 5 years was 71%. Adverse effects on the rate of restenosis were associated with male sex (p = .04), stenosis beginning at the origin of the renal artery (p = .01), and more than 20% residual stenosis after angioplasty (p = .02).Our results show that hypertension in children with renal artery stenosis caused by nonspecific aortoateritis can be safely treated by renal angioplasty with excellent midterm results. A long stenosis beginning at the origin of the artery predisposes to restenosis, but repeat dilatation often produces lasting benefit.
49. PO-0737: Predictors of PSA relapse in patients with intermediate risk prostate cancer treated with SBRT
- Author
-
H. Koneru, S. Guleria, Siyuan Lei, Simeng Suy, Thomas P. Kole, Brian T. Collins, Anatoly Dritschilo, O. Obayomi-Davies, Sean P. Collins, and T. Yung
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Hematology ,medicine.disease ,urologic and male genital diseases ,Psa relapse ,Prostate cancer ,Radiology Nuclear Medicine and imaging ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,In patient ,Intermediate risk ,business - Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.